You are here:

Category: 2.6 Nitrates calcium-channel blockers and other antianginal drugs

Name SMC ID No Manufacturer Status Sub. Type
 
ranolazine (Ranexa) 565/09 A Menarini Pharmaceuticals UK Ltd Not Recommended IRP
aliskiren (Rasilez) 462/08 Novartis Pharmaceuticals UK Ltd Not Recommended Resubmission
ranolazine (Ranexa) 565/09 A Menarini Pharmaceuticals UK Ltd Not Recommended Resubmission
ranolazine (Ranexa) 565/09 A Menarini Pharmaceuticals UK Ltd Not Recommended Resubmission
Ivabradine (Procoralan®) 319/06 Servier Laboratories Ltd Restricted Resubmission
aliskiren (Rasilez) 462/08 Novartis Pharmaceuticals UK Ltd Not Recommended Non submission
aliskiren (Rasilez) 462/08 Novartis Pharmaceuticals UK Ltd Not Recommended Full submission
ranolazine (Ranexa) 565/09 A Menarini Pharmaceuticals UK Ltd Not Recommended Full submission
ivabradine (Procoralan) 689/11 Servier Laboratories Ltd Not Recommended Non submission
ivabradine (Procoralan) 805/12 Servier Laboratories Ltd Restricted Full submission
defibrotide (Defitelio®) 967/14 Accepted Full submission
lercanidipine 20mg tablet (Zanidip) 315/06 Recordati Pharmaceuticals Accepted Abbreviated Submission
ivabradine 5mg, 7.5mg tablets (Procoralan) 319/06 Servier Laboratories Ltd Not Recommended Full submission
amlodipine besylate/valsartan (Exforge®) 350/07 Novartis Pharmaceuticals UK Ltd Accepted Abbreviated Submission
valsartan (Diovan) 351/07 Novartis Pharmaceuticals UK Ltd Accepted Abbreviated Submission

Back